Jill E. Skepner
Impact in
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- IL-33, ST2, and ILC Pathways
-
- Cancer Immunotherapy and Biomarkers
- Cytokine Signaling Pathways and Interactions
Papers in
-
- Psoriasis: Treatment and Pathogenesis 4
- Immunodeficiency and Autoimmune Disorders 2
- T-cell and B-cell Immunology 1
- IL-33, ST2, and ILC Pathways 1
-
- Eicosanoids and Hypertension Pharmacology 2
- Co-authors
- Jianfei Yang (4 shared papers)Mark S. Sundrud (3 shared papers)Tetsuya Yamagata (2 shared papers)Swetha Anandhan (1 shared paper)Ana Maria Aparicio (1 shared paper)Patrick Trojer (1 shared paper)Liangwen Xiong (1 shared paper)Jan Zhang (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (1 paper)Journal of Clinical Investigation (1 paper)Prostaglandins & Other Lipid Mediators (1 paper)Journal of Medicinal Chemistry (1 paper)Archivum Immunologiae et Therapiae Experimentalis (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Jill E. Skepner
8 papers receiving 808 citations
Peers
Comparison fields: 5 of 81
- Immunology 391
- Oncology 176
- Molecular Medicine 32
- Biochemistry 43
- Toxicology 18
Countries citing papers authored by Jill E. Skepner
This map shows the geographic impact of Jill E. Skepner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill E. Skepner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill E. Skepner more than expected).
Fields of papers citing papers by Jill E. Skepner
This network shows the impact of papers produced by Jill E. Skepner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill E. Skepner. The network helps show where Jill E. Skepner may publish in the future.
Co-authors
The 25 scholars most cited alongside Jill E. Skepner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 295 | |
| 2 | 2018 | 201 | |
| 3 | 2014 | 131 | |
| 4 | 2008 | 80 | |
| 5 | 2011 | 53 | |
| 6 | 2015 | 30 | |
| 7 | 2010 | 21 | |
| 8 | 2015 | 17 |
About Jill E. Skepner
Jill E. Skepner is a scholar working on Immunology, Biochemistry, Pathology and Forensic Medicine, Molecular Medicine and Pharmacology, having authored 8 papers that have together received 828 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (4 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Free Radicals and Antioxidants (1 paper), NF-κB Signaling Pathways (1 paper), T-cell and B-cell Immunology (1 paper), Autoimmune Bullous Skin Diseases (1 paper) and IL-33, ST2, and ILC Pathways (1 paper). The work is most often cited by research in Immunology (391 citations), Oncology (176 citations), Molecular Medicine (32 citations), Biochemistry (43 citations) and Toxicology (18 citations). Jill E. Skepner has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Jianfei Yang, Mark S. Sundrud, Tetsuya Yamagata, Swetha Anandhan, Ana Maria Aparicio, Patrick Trojer, Liangwen Xiong, Jan Zhang, Hao Zhao and Padmanee Sharma. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Investigation, Prostaglandins & Other Lipid Mediators, Journal of Medicinal Chemistry and Archivum Immunologiae et Therapiae Experimentalis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.